SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Paracelsian Inc (PRLN)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: WWS who wrote (353)8/31/1996 11:51:00 AM
From: Richard Mazzarella   of 4342
 
Bill, That's great, thanks for your post. The concern about "corner the market" is a good one. Maybe that is why they bought or bought the options for Chinese herbal supplies? Also, does anyone know the source for PN355 (Androvir)? I heard in the phone conference Dr. Babish say that they also have active compounds that they have synthesized. IMO even if someone could hold the market for the herbs, PRLN will have the patents for the effective combination of drugs and still receive their fair share from royalties. Good work Bill, these are the kinds of problems that could certainly change the financial value for us all long PRLN. Now I will send out a "scare balloon": How will PRLN get the funding to advance the business? If they go a Reg S route, that would kill the stock even though the business and management is fine. Does anyone have any insight on how other small biotechs have found funding?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext